How was published evidence used in model-based cost-utility analysis for lung cancer?

How was published evidence used in model-based cost-utility analysis for lung cancer?

Abstract Background Model-based cost-utility analysis (CUA) is a widely used method for evaluating the value of innovative medicines for lung cancer. However, comprehensive evidence exploring the sources of input parameters for CUA modeling is lacking. The objective of this study was to analyze the...

Full description

Saved in:
Bibliographic Details
Main Authors: Haijing Guan, Chunping Wang, Ruowei Xiao, Ting Zhou, Wei Li, Yanan Xu, Hongting Nie, Zhigang Zhao, Sheng Han, Feng Xie
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Health Economics Review
Subjects:
Economic evaluation
Cost-utility analysis
Sources of parameters
Model transparency
Lung cancer
Online Access:https://doi.org/10.1186/s13561-025-00651-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13561-025-00651-6

Similar Items